BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 34666605)

  • 21. Health Outcomes Among Patients Diagnosed with Schizophrenia in the US Veterans Health Administration Population Who Transitioned from Once-Monthly to Once-Every-3-Month Paliperidone Palmitate: An Observational Retrospective Analysis.
    Patel C; El Khoury A; Huang A; Wang L; Baser O; Joshi K
    Adv Ther; 2019 Oct; 36(10):2941-2953. PubMed ID: 31396809
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Direct and Indirect Healthcare Resource Utilization and Costs Among Migraine Patients in the United States.
    Bonafede M; Sapra S; Shah N; Tepper S; Cappell K; Desai P
    Headache; 2018 May; 58(5):700-714. PubMed ID: 29446063
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Healthcare resource utilization and direct medical costs associated with index and recurrent
    Feuerstadt P; Stong L; Dahdal DN; Sacks N; Lang K; Nelson WW
    J Med Econ; 2020 Jun; 23(6):603-609. PubMed ID: 31999199
    [No Abstract]   [Full Text] [Related]  

  • 24. Economic burden in patients with ALK + non-small cell lung cancer, with or without brain metastases, receiving second-line anaplastic lymphoma kinase (ALK) inhibitors.
    Lin HM; Pan X; Hou P; Huang H; Wu Y; Ren K; Jahanzeb M
    J Med Econ; 2020 Aug; 23(8):894-901. PubMed ID: 32347754
    [No Abstract]   [Full Text] [Related]  

  • 25. Health care burden and treatment patterns in commercially insured children with chronic idiopathic/spontaneous urticaria: A real-world study in the United States.
    Williams P; Kavati A; Pilon D; Xiao Y; Zhdanava M; Balp MM; Lefebvre P; Ortiz B; Hernandez-Trujillo V
    Allergy Asthma Proc; 2018 May; 39(3):201-211. PubMed ID: 29514728
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Economic Burden of Commercially Insured Patients With Major Depressive Disorder and Acute Suicidal Ideation or Behavior in the United States.
    Pilon D; Neslusan C; Zhdanava M; Sheehan JJ; Joshi K; Morrison L; Rossi C; Lefebvre P; Greenberg PE
    J Clin Psychiatry; 2022 Apr; 83(3):. PubMed ID: 35390231
    [No Abstract]   [Full Text] [Related]  

  • 27. Understanding healthcare burden and treatment patterns among young adults with schizophrenia.
    Huang A; Amos TB; Joshi K; Wang L; Nash A
    J Med Econ; 2018 Oct; 21(10):1026-1035. PubMed ID: 30001651
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Economic burden of skeletal-related events in patients with multiple myeloma: analysis of US commercial claims database.
    Bhowmik D; Hines DM; Intorcia M; Wade RL
    J Med Econ; 2018 Jun; 21(6):622-628. PubMed ID: 29571273
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Healthcare resource utilization among commercially insured patients with cold agglutinin disease in the United States.
    Su J; Bylsma LC; Jiang X; Morales Arias J; Jain N; Nordyke RJ
    J Med Econ; 2020 Aug; 23(8):902-907. PubMed ID: 32362156
    [No Abstract]   [Full Text] [Related]  

  • 30. Antipsychotic Adherence, Resource Use, and Costs Before and After the Initiation of Once-monthly Paliperidone Palmitate Therapy Among Medicaid Beneficiaries With Prior Schizophrenia Relapse.
    Zhdanava M; Lin D; Lafeuille MH; Ghelerter I; Morrison L; Lefebvre P; Joshi K
    Clin Ther; 2021 Mar; 43(3):535-548. PubMed ID: 33589216
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Healthcare utilization and cost burden among women with endometriosis by opioid prescription status in the first year after diagnosis: a retrospective claims database analysis.
    As-Sanie S; Soliman AM; Evans K; Erpelding N; Lanier R; Katz NP
    J Med Econ; 2020 Apr; 23(4):371-377. PubMed ID: 31856613
    [No Abstract]   [Full Text] [Related]  

  • 32. Clinical and economic burden of peripheral T-cell lymphoma in commercially insured patients in the United States: findings using real-world claims data.
    Burudpakdee C; Lin HM; Wang W; Seetasith A; Zhu Y; Bonthapally V; Carson KR
    J Med Econ; 2016 Oct; 19(10):965-72. PubMed ID: 27152635
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The economic burden of psoriasis with high comorbidity among privately insured patients in the United States.
    Pilon D; Teeple A; Zhdanava M; Ladouceur M; Ching Cheung H; Muser E; Lefebvre P
    J Med Econ; 2019 Feb; 22(2):196-203. PubMed ID: 30523738
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Treatment patterns, health resource utilization and costs among central precocious puberty patients treated with leuprolide or histrelin: an examination of the commercial and Medicaid populations.
    Klein KO; Soliman AM; Bonafede M; Nelson JK; Grubb E
    J Med Econ; 2020 Apr; 23(4):407-414. PubMed ID: 31766907
    [No Abstract]   [Full Text] [Related]  

  • 35. Incidence of corneal adverse events in patients with multiple myeloma and their clinical and economic impact: A real-world retrospective cohort study.
    Wang F; Sansbury L; Ferrante S; Maiese EM; Willson J; Chen CC; Nunna S; Sun K; Kleinman DM
    J Med Econ; 2022; 25(1):182-192. PubMed ID: 35023807
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Economic burden of generalized myasthenia gravis (MG) in the United States and the impact of common comorbidities and acute MG-events.
    Zhdanava M; Pesa J; Boonmak P; Cai Q; Pilon D; Choudhry Z; Souayah N
    Curr Med Res Opin; 2024 May; ():1-9. PubMed ID: 38745448
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Treatment Patterns, Acute Healthcare Resource Use, and Costs of Patients with Treatment-Resistant Depression Completing Induction Phase of Esketamine in the United States.
    Harding L; Joshi K; Zhdanava M; Shah A; Voegel A; Chen C; Pilon D
    Drugs Real World Outcomes; 2024 Jun; 11(2):209-219. PubMed ID: 38727888
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Impact of mental health comorbidities on health care utilization and expenditure in a large US managed care adult population with ADHD.
    Kawatkar AA; Knight TK; Moss RA; Sikirica V; Chu LH; Hodgkins P; Haim Erder M; Nichol MB
    Value Health; 2014 Sep; 17(6):661-8. PubMed ID: 25236989
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Healthcare costs and resource utilization in patients with severe aplastic anemia in the US.
    Cai B; Said Q; Li X; Li FY; Arcona S
    J Med Econ; 2019 Oct; 22(10):1055-1062. PubMed ID: 31296074
    [No Abstract]   [Full Text] [Related]  

  • 40. Long-term direct and indirect costs of ulcerative colitis in a privately-insured United States population.
    Pilon D; Ding Z; Muser E; Obando C; Voelker J; Manceur AM; Kinkead F; Lafeuille MH; Lefebvre P
    Curr Med Res Opin; 2020 Aug; 36(8):1285-1294. PubMed ID: 32427006
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.